Disease/Infection News

RSS

Phase I clinical trial of XRX-001 for yellow fever initiated

Xcellerex, Inc. today announced that it has initiated a Phase I clinical trial of XRX-001, a novel, prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.

12 Jan 2010

Criminal prosecution on Salmonella outbreak is yet to begin

Over a year after the outbreak of Salmonella in peanut butter that sickened hundreds and caused the deaths of at least nine, criminal prosecution of the responsible parties has yet to begin.

12 Jan 2010

Cytheris commences enrollment in its recombinant human Interleukin-7 INSPIRE 2 program for HIV

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).

12 Jan 2010

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

NanoViricides, Inc. (the "Company"), reports that the Company has been invited to present on January 12th at the Biotech Showcase™, a conference designed to showcase promising companies and technologies for partnering and investment purposes.

12 Jan 2010

NVHR supports IOM report on inadequate federal funding for chronic viral hepatitis

With today's release of a landmark study by the Institute of Medicine (IOM), Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C, finding that inadequate public-health resources are being allocated to national and local prevention, control, and surveillance programs, the National Viral Hepatitis Roundtable (NVHR) today renewed its call for the Administration, Congress, and the entire health care system to take immediate and decisive action to implement the report's key recommendations.

12 Jan 2010

Department of Health vaccinates 49,078 Pennsylvanians at 33 H1N1 flu clinics

The Department of Health vaccinated 49,078 Pennsylvanians at 33 H1N1 flu clinics held across the state on Jan. 8 and 9. The department urges anyone who has not yet been vaccinated to get immunized.

12 Jan 2010

American Heart Association encourages more Americans to get vaccinated against H1N1

The American Heart Association supports National Influenza Vaccination Week, Jan. 10-16, an effort led by the Department of Health and Human Services and the Centers for Disease Control and Prevention (CDC) to encourage more Americans to get vaccinated against H1N1.

12 Jan 2010

KKESH in Saudi Arabia and U.S. Johns Hopkins Medicine announce collaboration

The Wilmer Eye Institute of Johns Hopkins Medicine in Baltimore (USA) announced today that it will collaborate in research, education and patient care with the King Khaled Eye Specialist Hospital in Riyadh (Saudi Arabia).

12 Jan 2010

New findings would allow doctors to tailor drug cocktails for particular viral strains

Chemists at UC San Diego and statisticians at Harvard University have developed a novel way to trace mutations in HIV that lead to drug resistance. Their findings, once expanded to the full range of drugs available to treat the infection, would allow doctors to tailor drug cocktails to the particular strains of the virus found in individual patients.

12 Jan 2010

CVS/pharmacy and MinuteClinic urge Americans to protect themselves with H1N1 vaccine

CVS/pharmacy, the nation's leading retail pharmacy and MinuteClinic, the largest retail health care provider in the U.S., is urging more Americans to protect themselves and their families with an H1N1 vaccine during National Influenza Vaccination Week (January 10-16) as designated by U.S. Department of Health and Human Services Secretary Kathleen Sebelius and the Centers for Disease Control and Prevention (CDC).

12 Jan 2010

American Red Cross urges Americans to get vaccinated against H1N1 virus

The H1N1 (swine) flu virus is still prevalent across the nation, and the American Red Cross encourages everyone to get vaccinated against the virus, now that the vaccine is widely available.

12 Jan 2010

Pfizer commences recruitment for Phase I clinical trial of SA3Ag vaccine

Inhibitex, Inc. today announced that its collaborator, Pfizer, Inc., has initiated patient recruitment for 408-patient, randomized, double-blind Phase I clinical trial to evaluate the safety, tolerability, and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus (S. aureus) vaccine (SA3Ag) in healthy adults.

12 Jan 2010

H1N1 flu vaccines and other resources for remaining healthy to be offered at Pennsylvania Farm Show

The Department of Health is offering free H1N1 flu vaccines and other resources for remaining healthy at its exhibit at the Pennsylvania Farm Show, which runs through Jan. 16.

12 Jan 2010

AHF to host protest targeting Merck over the steep price for its key HIV/AIDS drug, Isentress

AIDS Healthcare Foundation (AHF) will host a protest Tuesday, January 12, at 10:30am targeting Merck and Co. Pharmaceuticals over the steep price for its key HIV/AIDS drug, Isentress, during the 28th Annual J.P. Morgan Healthcare Conference in San Francisco.

12 Jan 2010

Research suggests ancient Egyptians may have used lead-based cosmetics to prevent eye infections

There's more to the eye makeup that gave Queen Nefertiti and other ancient Egyptian royals those stupendous gazes and legendary beauty than meets the eye. Scientists in France are reporting that the alluring eye makeup also may have been used to help prevent or treat eye disease by doubling as an infection-fighter.

12 Jan 2010

Sorrento Therapeutics, Scripps Research Institute announce antibody development collaboration

Sorrento Therapeutics, Inc. today announced an antibody discovery and development collaboration with The Scripps Research Institute, La Jolla, CA. Under the terms of the agreement, Sorrento Therapeutics obtains an exclusive, worldwide license to the Institute's novel technology, based on quorum sensing, for the prevention and treatment of Staphylococcus aureus ('Staph') infections, including Methicillin-resistant Staph. aureus (MRSA).

12 Jan 2010

AvidBiotics and Ecolab to develop new technology that reduces food pathogens in meat products

AvidBiotics Corp. and Ecolab Inc. today announced an agreement under which they will work to develop a new technology to dramatically reduce the presence of the dangerous pathogen E. coli O157:H7 in red meat products.

12 Jan 2010

U.S. changes HIV policy to allow foreigners with virus to enter

Los Angeles Times: "Last Monday, for the first time in 22 years, foreigners with HIV were legally allowed to enter the United States without their infection status being considered. Before that, even short-term visitors had to receive special permission — or lie on their visa application — to come here.

12 Jan 2010

Public awareness campaign needed to curb health threats posed by hepatitis B and hepatitis C

Stepped-up vaccination requirements, a boost in resources for prevention and treatment, and a public awareness campaign similar to the effort that dispelled the stigma of HIV/AIDS are needed to curb the health threats posed by hepatitis B and hepatitis C, says a new report from the Institute of Medicine.

12 Jan 2010

Insecticide-treated net reduces malaria infection in pregnant women, but simple measures needed to increase effectiveness

A Tanzanian program to supply insecticide treated nets to prevent malaria in pregnant women successfully delivers the intervention to only 30% of women, but simple changes could increase effectiveness, according to an article http://www.cmaj.ca/embargo/cmaj090268.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

12 Jan 2010

Disease/Infection News

Phase I clinical trial of XRX-001 for yellow fever initiated

Criminal prosecution on Salmonella outbreak is yet to begin

Cytheris commences enrollment in its recombinant human Interleukin-7 INSPIRE 2 program for HIV

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

NVHR supports IOM report on inadequate federal funding for chronic viral hepatitis

Department of Health vaccinates 49,078 Pennsylvanians at 33 H1N1 flu clinics

American Heart Association encourages more Americans to get vaccinated against H1N1

KKESH in Saudi Arabia and U.S. Johns Hopkins Medicine announce collaboration

New findings would allow doctors to tailor drug cocktails for particular viral strains

CVS/pharmacy and MinuteClinic urge Americans to protect themselves with H1N1 vaccine

American Red Cross urges Americans to get vaccinated against H1N1 virus

Pfizer commences recruitment for Phase I clinical trial of SA3Ag vaccine

H1N1 flu vaccines and other resources for remaining healthy to be offered at Pennsylvania Farm Show

AHF to host protest targeting Merck over the steep price for its key HIV/AIDS drug, Isentress

Research suggests ancient Egyptians may have used lead-based cosmetics to prevent eye infections

Sorrento Therapeutics, Scripps Research Institute announce antibody development collaboration

AvidBiotics and Ecolab to develop new technology that reduces food pathogens in meat products

U.S. changes HIV policy to allow foreigners with virus to enter

Public awareness campaign needed to curb health threats posed by hepatitis B and hepatitis C

Insecticide-treated net reduces malaria infection in pregnant women, but simple measures needed to increase effectiveness

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News